Penserra Capital Management LLC Akouos, Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$7.65 - $11.38 $6,005 - $8,933
-785 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$11.87 - $15.96 $118 - $159
10 Added 1.29%
785 $9,000
Q1 2021

May 13, 2021
SELL
$13.87 - $21.04 $208 - $315
-15 Reduced 1.9%
775 $10,000
Q4 2020

Feb 12, 2021
BUY
$17.03 - $22.45 $13,453 - $17,735
790 New
790 $15,000

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email